InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Teper Daniel Gedeon. Director active across 1 company, notably IMMUNE PHARMACEUTICALS INC. Cumulatively, 4 disclosures have been recorded. Split: 4 buys · 0 sell. Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Teper Daniel Gedeon is a declarant linked to IMMUNE PHARMACEUTICALS INC (XNAS), where he is listed as CEO. The 4 total filings cover, in the sampled recent filings, the period from 2016-01-06 to 2016-01-26 and relate to acquisitions.